You are here

RBX2660

Go or no go? Bristol’s Tyk2 test

EP Vantage

Wed, 08/31/22 - 10:15 am

Bristol Myers Squibb

deucravacitinib

Amylyx Pharmaceuticals

Ferring Pharmaceuticals

Revance Therapeutics

Spectrum Pharmaceuticals

FDA's vaccine adcomm to review first fecal transplant to treat C. difficile infections

Endpoints

Mon, 08/8/22 - 11:39 pm

Ferring Pharmaceuticals

Ferring’s gut microbiome drug clears phase 3 trial in C. diff

Pharmaforum

Thu, 05/7/20 - 10:41 am

Ferring Pharmaceuticals

clinical trials

Rebiotix to Present Data From First-In-Class Microbiota Restoration Therapy at IDWeek 2018

CP Wire

Tue, 10/2/18 - 09:54 am

Rebiotix to Present Data From First-In-Class Microbiota Restoration Therapy at IDWeek 2018

Mon, 10/1/18 - 11:29 pm